Literature DB >> 29416110

Perforin proteostasis is regulated through its C2 domain: supra-physiological cell death mediated by T431D-perforin.

Amelia J Brennan1, Ruby H P Law2,3, Paul J Conroy2,3, Tahereh Noori4, Natalya Lukoyanova5, Helen Saibil5, Hideo Yagita6, Annette Ciccone7, Sandra Verschoor7, James C Whisstock2,3, Joseph A Trapani7,8, Ilia Voskoboinik9,10.   

Abstract

The pore forming, Ca2+-dependent protein, perforin, is essential for the function of cytotoxic lymphocytes, which are at the frontline of immune defence against pathogens and cancer. Perforin is a glycoprotein stored in the secretory granules prior to release into the immune synapse. Congenital perforin deficiency causes fatal immune dysregulation, and is associated with various haematological malignancies. At least 50% of pathological missense mutations in perforin result in protein misfolding and retention in the endoplasmic reticulum. However, the regulation of perforin proteostasis remains unexplored. Using a variety of biochemical assays that assess protein stability and acquisition of complex glycosylation, we demonstrated that the binding of Ca2+ to the C2 domain stabilises perforin and regulates its export from the endoplasmic reticulum to the secretory granules. As perforin is a thermo-labile protein, we hypothesised that by altering its C2 domain it may be possible to improve protein stability. On the basis of the X-ray crystal structure of the perforin C2 domain, we designed a mutation (T431D) in the Ca2+ binding loop. Mutant perforin displayed markedly enhanced thermal stability and lytic function, despite its trafficking from the endoplasmic reticulum remaining unchanged. Furthermore, by introducing the T431D mutation into A90V perforin, a pathogenic mutation, which results in protein misfolding, we corrected the A90V folding defect and completely restored perforin's cytotoxic function. These results revealed an unexpected role for the Ca2+-dependent C2 domain in maintaining perforin proteostasis and demonstrated the possibility of designing perforin with supra-physiological cytotoxic function through stabilisation of the C2 domain.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29416110      PMCID: PMC6113324          DOI: 10.1038/s41418-018-0057-z

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  31 in total

1.  An adaptable standard for protein export from the endoplasmic reticulum.

Authors:  R Luke Wiseman; Evan T Powers; Joel N Buxbaum; Jeffery W Kelly; William E Balch
Journal:  Cell       Date:  2007-11-16       Impact factor: 41.582

2.  Perforin activity and immune homeostasis: the common A91V polymorphism in perforin results in both presynaptic and postsynaptic defects in function.

Authors:  Ilia Voskoboinik; Vivien R Sutton; Annette Ciccone; Colin M House; Jenny Chia; Phillip K Darcy; Hideo Yagita; Joseph A Trapani
Journal:  Blood       Date:  2007-05-02       Impact factor: 22.113

3.  A single amino acid change, A91V, leads to conformational changes that can impair processing to the active form of perforin.

Authors:  Christina Trambas; Federico Gallo; Daniela Pende; Stefania Marcenaro; Lorenzo Moretta; Carmela De Fusco; Alessandra Santoro; Luigi Notarangelo; Maurizio Arico; Gillian M Griffiths
Journal:  Blood       Date:  2005-03-01       Impact factor: 22.113

4.  A functional analysis of the putative polymorphisms A91V and N252S and 22 missense perforin mutations associated with familial hemophagocytic lymphohistiocytosis.

Authors:  Ilia Voskoboinik; Marie-Claude Thia; Joseph A Trapani
Journal:  Blood       Date:  2005-03-08       Impact factor: 22.113

5.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

6.  Structural Basis for Ca2+-mediated Interaction of the Perforin C2 Domain with Lipid Membranes.

Authors:  Hiromasa Yagi; Paul J Conroy; Eleanor W W Leung; Ruby H P Law; Joseph A Trapani; Ilia Voskoboinik; James C Whisstock; Raymond S Norton
Journal:  J Biol Chem       Date:  2015-08-25       Impact factor: 5.157

7.  Temperature sensitivity of human perforin mutants unmasks subtotal loss of cytotoxicity, delayed FHL, and a predisposition to cancer.

Authors:  Jenny Chia; Kim Pin Yeo; James C Whisstock; Michelle A Dunstone; Joseph A Trapani; Ilia Voskoboinik
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-01       Impact factor: 11.205

8.  How good are my data and what is the resolution?

Authors:  Philip R Evans; Garib N Murshudov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-06-13

9.  The functional basis for hemophagocytic lymphohistiocytosis in a patient with co-inherited missense mutations in the perforin (PFN1) gene.

Authors:  Ilia Voskoboinik; Marie-Claude Thia; Annette De Bono; Kylie Browne; Erika Cretney; Jacob T Jackson; Phillip K Darcy; Stephen M Jane; Mark J Smyth; Joseph A Trapani
Journal:  J Exp Med       Date:  2004-09-14       Impact factor: 14.307

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  2 in total

1.  Chemical priming of natural killer cells with branched polyethylenimine for cancer immunotherapy.

Authors:  Seung Hee Choi; Hye Jin Kim; Joo Dong Park; Eun-Su Ko; Minwook Lee; Dae-Keum Lee; Jin-Ho Choi; Hye Jung Jang; Isaac Kim; Hae-Yun Jung; Keun-Hong Park; Kyung-Soon Park
Journal:  J Immunother Cancer       Date:  2022-08       Impact factor: 12.469

2.  Degranulation enhances presynaptic membrane packing, which protects NK cells from perforin-mediated autolysis.

Authors:  Yu Li; Jordan S Orange
Journal:  PLoS Biol       Date:  2021-08-03       Impact factor: 8.029

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.